Regulatory Context According to MEDVi's published disclaimers: "The telehealth weight loss and prescription compounding industries have been under increased regulatory scrutiny in recent years." The FDA continues issuing guidance on compounding practices
GLP-1s stimulate insulin release, reduce blood sugar levels, and promote satiety (fullness)
BPC-157 Peptide Regulatory Status in Canada Health Canada Regulatory Status BPC-157 is not an authorized health product in Canada and does not carry a Drug Identification Number (DIN), Natural Product Number (NPN), or Homeopathic Drug Number (DIN-HM) issued by Health Canada
Surv Ophthalmol 1995;40:136-144
Microneedling is typically not painful, as a numbing cream is applied to the treatment area beforehand
Brand-name pens (Ozempic, Wegovy, Mounjaro, Zepbound) undergo extensive stability testing by the manufacturer